Prostate cancer decisions — 2025

The Board remanded the claim for service connection for the cause of death due to errors in assisting the veteran. The Veteran's exposure to herbicide agents is presumed.

The appeal for a higher disability rating for prostate cancer residuals was sent back to the VA for further evaluation. The VA needs to conduct an in-person medical exam.

The veteran's service-connected PTSD and prostate cancer residuals prevent him from obtaining or maintaining gainful employment, so he is granted total disability on individual unemployability (TDIU) effective December 30, 2022.

The veteran's service-connected PTSD and prostate cancer residuals prevent him from obtaining or maintaining gainful employment, so he is granted total disability on individual unemployability (TDIU) effective December 30, 2022.

The veteran's claims for service connection for prostate cancer with incontinence and erectile dysfunction were granted.

The Board remanded the veteran's claims for service connection of prostate cancer, hypertension, diabetes mellitus type II, and peripheral neuropathy in both lower extremities due to exposure to ionizing radiation. The Board found that additional medical opinions are needed.

The Board dismissed the veteran's appeal for an earlier effective date for service connection of metastasis to pelvis and special monthly compensation based on housebound criteria due to procedural defects.

The appeal for service connection of prostate cancer is remanded because the veteran was not given notice of his right to a hearing.

The Board remanded the claims for sinusitis and tension headaches due to new evidence. All other conditions were denied.

The veteran's claims for left and right lower extremity radiculopathy sciatica, and knee strains were granted as secondary to a service-connected lumbar spine condition. The claim for bilateral hearing loss was denied. Other conditions were remanded.

The Veteran's claim for service connection for basal cell carcinoma was granted. The claims for service connection for neoplasms of the male reproductive system, including prostate cancer, and Parkinsonism due to TERA exposure were remanded.

The Board remanded the veteran's claims for service connection for several conditions, including hypertension, heart disorder, edema of the lower extremities, prostate disorder, and urinary tract disorder. The Board also directed further development to verify the veteran's exposure to Agent Orange while stationed in Japan.

The Board denied service connection for diabetes mellitus, type II and prostate cancer as the Veteran did not have these conditions during service or within one year of discharge. The appeal was based on exposure to herbicide agents, but there is no evidence of such exposure.

The Board remanded the veteran's claims for service connection of prostate cancer and erectile dysfunction, finding that further medical evidence is needed to determine if these conditions are related to his service at Camp Lejeune.

The Board remanded the case to obtain a new medical opinion on whether prostate cancer is service-connected, considering toxic exposures during military service.

The Veteran's claims for service connection for prostate cancer and coronary artery disease (CAD) were granted. The claim for stable angina was remanded for further evaluation.

The appeal for service connection of prostate cancer is remanded. The VA will obtain missing medical records and a new medical opinion.

The Board denied the veteran's motion to revise or reverse a previous decision that did not grant service connection for loss of sphincter control. The Board found no clear and unmistakable error in the original decision.

The Board granted the Veteran's appeal, finding that the severance of service connection for bladder cancer, prostate cancer, kidney disease, scars, and hypertension was improper. The Board also granted the appeal for the severance of Special Monthly Compensation (SMC) based on statutory housebound and Dependents' Educational Assistance (DEA).

The veteran's request for a higher disability rating for prostate cancer residuals was denied. The appeal for special monthly compensation based on housebound criteria was dismissed as moot.